Confidentiality AgreementConfidentiality Agreement • February 3rd, 2021
Contract Type FiledFebruary 3rd, 2021and FDA Laboratories are prepared to exchange information to determine the feasibility of working together in the area of testing services, (the "Program") and it will be necessary for both parties to disclose to ea ch other certain valuable business, technical and/or trade secret information relating to the above. Such valuable business, technical and trade secret information shall be marked as confidential, or if disclosed orally, shall be confirmed in writing as confidenti al within thirty (30) days of its disclosure to be considered as "Confidential Information". It is agreed that each disclosing party is willing to disclose such Confidential Information under the conditions specified below: